April 01, 2014 9:25am EDT
Download as PDF
Adam Logal Appointed Senior Vice President, Chief Financial Officer
Arie Gutman Appointed Chief Executive Officer of OPKO’s Active
Pharmaceutical Ingredient and Chemical Development Division
MIAMI--(BUSINESS WIRE)--
OPKO Health, Inc. (NYSE: OPK )
today announced the appointment of Adam Logal as Senior Vice President,
Chief Financial Officer. Additionally, Arie Gutman Ph.D. was appointed
Chief Executive Officer of OPKO’s newly created Active Pharmaceutical
Ingredient and Chemical Development Division.
Mr. Logal, currently Vice President, Finance, Chief Accounting Officer
and Treasurer, succeeds Juan F. Rodriguez, who will continue to provide
services to OPKO as a consultant while he pursues personal business
interests. “Adam has been a key leader in our organization since our
inception in 2007. His knowledge of our business, versatility as a
finance leader and his strategic insights are valued by leaders across
the Company,” said Phillip Frost, M.D., Chairman and Chief Executive
Officer of OPKO. “I am delighted that Adam will continue to help lead
the Company through our near term commercial opportunities and help
position us for long-term success.”
Dr. Gutman founded FineTech Pharmaceutical Ltd. (“FineTech”), a highly
profitable FDA approved business specializing in the development and
manufacture of complex active pharmaceutical ingredients which OPKO
acquired in December 2011. Under Dr. Gutman’s leadership as its
President and CEO, FineTech has partnered with generic pharmaceutical
companies initiating several “first to file” paragraph IV opportunities
that led to successful launches of specialty generic drugs. With his
appointment as Chief Executive Officer of OPKO’s Active Pharmaceutical
Ingredient and Chemical Development Division, Dr. Gutman will lead
efforts to develop additional chemistry based businesses and also ensure
in-house availability of advanced synthetic capabilities for OPKO’s
internal drug and diagnostic development programs.
About OPKO
OPKO is a multinational biopharmaceutical and diagnostics company that
seeks to establish industry leading positions in large, rapidly growing
markets by leveraging its discovery, development and commercialization
expertise and novel and proprietary technologies.
This press release contains "forward-looking statements," as that
term is defined under the Private Securities Litigation Reform Act of
1995 (PSLRA), which statements may be identified by words such as
"expects," "plans," "projects," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates," and other words of similar
meaning, including all non-historical statements about our expectations,
beliefs or intentions regarding our business, technologies and products,
financial condition, strategies, prospects, growth opportunities, and
management. Many factors could cause our actual activities or results to
differ materially from the activities and results anticipated in
forward-looking statements. These factors include those described in our
filings with the Securities and Exchange Commission, and risks inherent
in funding, developing and obtaining regulatory approvals of new,
commercially-viable and competitive products and treatments. In
addition, forward-looking statements may also be adversely affected by
general market factors, competitive product development, product
availability, federal and state regulations and legislation, the
regulatory process for new products and indications, manufacturing
issues that may arise, patent positions and litigation, among other
factors. The forward-looking statements contained in this press release
speak only as of the date the statements were made, and, except as
required by applicable law, we do not undertake any obligation to update
forward-looking statements. We intend that all forward-looking
statements be subject to the safe-harbor provisions of the PSLRA.
OPKO Health, Inc.
Steven D. Rubin or Adam Logal,
Source: OPKO Health, Inc.
Released April 1, 2014
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page